DCF — PIEDMONT MEDICAL CENTER
Enterprise Value: $258.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$258.1M
Enterprise Value
$66.2M
PV of Cash Flows
$191.9M
PV of Terminal Value
$309.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $398.6M | $35.0M | 9.0% | $11.9M | $10.8M |
| Year 2 | $410.5M | $40.2M | 10.0% | $15.3M | $12.7M |
| Year 3 | $422.8M | $45.6M | 11.0% | $18.9M | $14.2M |
| Year 4 | $435.5M | $49.1M | 11.0% | $21.1M | $14.4M |
| Year 5 | $448.6M | $51.7M | 12.0% | $22.6M | $14.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $258.1M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$387.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08282336370460407
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5